MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Health / Surgery
Written by / Agency / Source: Market Research Reports
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

MarketResearchReports.biz Publishes Companion Diagnostics and Personalized Medicine Market Report 2012 - New market research report added in MarketResearchReports.Biz database Companion Diagnostics and personalized Medicine Market Report 2012
MarketResearchReports.biz Publishes Companion Diagnostics and Personalized Medicine Market Report 2012

 

NewswireToday - /newswire/ - Pune, Maharashtra, India, 2013/03/11 - New market research report added in MarketResearchReports.Biz database Companion Diagnostics and personalized Medicine Market Report 2012.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

This is the latest and most up-to-date Market Report from Select Biosciences addressing the companion diagnostics (CDx) and personalized medicine marketplace.Personalized medicine is a broad field with several stakeholders all of which must be aligned in order to capture the immense potential value in targeting therapeutics to the correct patient population the field of stratified medicine.

Companion Diagnostics has been rapidly expanding over the past 3 years and in this market report we describe the current state of the marketplace from the following perspectives:

• All the Prognostic and Predictive Biomarkers with Potential Clinical Utility are described a few have already been developed into CDx and we expect growth in this space
• Targeted Therapeutics, Associated Biomarkers, Therapeutic Indications, and Testing Mandates are Described
• Companion Diagnostics Partnerships and Collaborations from 2009 to 2012 are Presented Provides an Up-to-Date State of the Industry Describing the Disease Areas being Addressed and Types of Biomarkers Being Deployed
• Quantitative Market Metrics
• Quantitative Market Forecast: Market Sizing and Growth Rate
• Revenue Breakout: Rx versus Dx
• Targeted Rx and CDx Pricing
• Publication Hotspot Analyses of the Various Cancer Biomarker Classes for Identifying Niches of Market Opportunity in Various Disease Classes
This data-driven characterization of the Companion Diagnostics and Personalized Medicine field is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans this Market Report is written and delivered to customers in PowerPoint format.

Extensive Market Analyses Presented in this Report

Personalized Medicine and Companion Diagnostics: Market Segmentation and Quantitative Analysis

• Prognostic Biomarkers in Cancer Listing, Description, and Clinical Significance
• Predictive Biomarkers in Cancer Listing, Description, and Clinical Significance
• Summary of Pathways to Regulatory Approval of Companion Diagnostics
• LDTs under CLIA Certification
• Outcomes with Drugs in Various Disease Classes
• Percent of Tumor Classes where Tumors are Associated with Characterized Somatic Mutations
• Companion Diagnostics and Personalized Medicine: Quantitative Market Metrics
• How Much Does it Cost to Develop a Companion Diagnostic?
• Precedent for Premium Pricing in Cancer Targeted Therapeutics
• Pricing of Selected Personalized Medicine Tests
• Growth of the Personalized Medicine Marketplace: Market Size/Forecast and Growth Rate
Personalized Medicine Industry Landscape: Selected Indications, Biomarkers and Therapeutics

Market Trends and Evolution of the CDx Marketplace

• Disparities between Rx and CDx Companies
• Varying Economic Incentives between Rx and Dx Development
• Increasing Targeted Rx in the Oncology Space and Effect on CDx Development
• Current Rx/CDx Co-development Programs in Phase III Trials with Listing of Associated Biomarkers
• Cancer Classes Addressable by CDx
• Characterization of Molecular Biomarker Classes: Hotspot Analysis of Publications
• Cancer Biomarkers
• Oncogenes
• Tumor Suppressor Genes
• Non-coding RNAs
Collaborations and Partnering in the CDx Space

• 2012
• 2011
• 2010
• 2009

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Market Research Reports

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health / Surgery articles,
CATCH Visitors via Your Competitors Announcements!


MarketResearchReports.biz Publishes Companion Diagnostics and Personalized Medicine Market Report 2012

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Hemendra Parmar - MarketResearchReports.biz 
+91 86 00166670 hemendra[.]marketresearchreports.biz
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Market Research Reports securities in any jurisdiction including any other companies listed or named in this release.

Health / Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Market Research Reports / Company Profile


Read Health / Surgery Most Recent Related Newswires:

SCBIO Executive Erin Ford Appointed to South Carolina District Export Council for 2020-2021
University of the Ryukyus and NEC Discover a Novel Diagnostic Biomarker for Acute Adult T-cell Leukemia/lymphoma
Change Healthcare Recognized by Frost & Sullivan for Accelerating Claims Processing with its Intelligent Healthcare Network™ Blockchain Technology
SCBIO CEO Sam Konduros Named to South Carolina Chamber Executive Committee
Frost & Sullivan Defines Top Femtech Global Opportunities by 2024
Frost & Sullivan Highlights on Impact of the Coronavirus on Business
Global Healthcare to Soar Above Trillion in 2020 with Consumerism and Outcome-based Care Models Finds Frost & Sullivan
Demand for CROs Rises to Strike Evolving Clinical Trial Models for Target Therapies Reports Frost & Sullivan
PointClickCare Integrated Care Coordination Platform Applauded by Frost & Sullivan
Inkwood Research Publishes Global Genetic Testing Market Forecast 2019-2027
NEC and VAXIMM Announce Collaboration to Advance Personalized Neoantigen Cancer Vaccines
Alopecia Hair Loss Treatment Market is Advancing At A CAGR of 5.51% by 2027 According to Inkwood Research
Frost & Sullivan Distinguishes Inovalon as Company of the Year for Advancing the Healthcare Industry by Harnessing Massive-Scale Data
South Carolina Life Sciences Industry Honors USC’s Dr. Harris Pastides, AVX Corporation
Neurodegenerative Disorder Therapeutics Market Sees a Silver Lining with Cell and Gene Therapies Finds Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)